ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis

October 19, 2012

55 NCI Grantees Win Shannon Awards, NCI gets $5.2 Mil.

October 4, 1991

DCPC Board approves 7 New RFAs, 2 Pas

October 21, 1994

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995